| 2024/10/18 22:26:35 | |
|---|---|
| Price | |
| 6.476 EUR | |
| Difference | -2.26% (-0.15) |
General attributes
| ISIN | CA05156V1022 |
| Symbol | AUPH |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 928 EUR |
| Benchmark | S&P/TSX 60 INDEX |
Market data
| Bid (Bid size) | 6.412 EUR (260) |
| Ask (Ask size) | 6.54 EUR (260) |
| Open | 6.558 EUR |
| High | 6.558 EUR |
| Low | 6.558 EUR |
| Close (prev. day) | 6.626 EUR |
| VWAP | 6.558 EUR |
| Volume (pcs) | 200 |
| Trading volume | 1,311.60 |
| Number of trades | 1 |
| Last size | 200 |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/09/27 |
|
Global Equity Ratings |
|
| 2024/09/11 |
|
Global Equity Ratings |
|
| 2024/09/05 |
|
Global Equity Ratings |
|
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/10/18 22:26:35 | |
|---|---|
| Price | |
| 6.476 EUR | |
| Difference | -2.26% (-0.15) |
General attributes
| ISIN | CA05156V1022 |
| Symbol | AUPH |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 928 EUR |
| Benchmark | S&P/TSX 60 INDEX |
Market data
| Bid (Bid size) | 6.412 EUR (260) |
| Ask (Ask size) | 6.54 EUR (260) |
| Open | 6.558 EUR |
| High | 6.558 EUR |
| Low | 6.558 EUR |
| Close (prev. day) | 6.626 EUR |
| VWAP | 6.558 EUR |
| Volume (pcs) | 200 |
| Trading volume | 1,311.60 |
| Number of trades | 1 |
| Last size | 200 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +44.96% | -10.04% | -61.39% |
| Perf (abs.) | +2.03 | -0.73 | -10.43 |
| Beta | 0.89 | 1.17 | 1.57 |
| Volatility | 42.32 | 52.56 | 76.71 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 6.585 EUR (44) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 6.378 EUR (92) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 5.642 EUR (238) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 6.053 EUR (712) |
| YTD High | date | 8.530 EUR (2024/01/09) |
| YTD Low | date | 4.420 EUR (2024/06/13) |
| 52 Weeks High | date | 9.010 EUR (2023/11/21) |
| 52 Weeks Low | date | 4.420 EUR (2024/06/13) |
All listings for AURINIA PHARMACEUTICALS INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/10/18 | 22:26 | 6.476 EUR | 0.00 | 1 |
| Stuttgart | 2024/10/18 | 21:31 | 6.554 EUR | 0.00 | 4 |
| Nasdaq | 2024/10/18 | 22:00 | 7.03 USD | 7.64 | 9,356 |
| Munich | 2024/10/18 | 08:01 | 6.556 EUR | 0.00 | 2 |
| London Stock Exchange | 2021/02/05 | 16:52 | 19.6090 CAD | 0.00 | 1 |
| Frankfurt | 2024/10/18 | 09:27 | 6.454 EUR | 0.00 | 2 |
| Duesseldorf | 2024/10/18 | 19:32 | 6.562 EUR | 0.00 | 7 |
| Berlin | 2024/10/18 | 08:13 | 6.556 EUR | 0.00 | 2 |
Company Profile
| - |
Board of directors
| Daniel Billen | Chairman of Supervisory Board |
| Brinda Balakrishnan | Member of Supervisory Board |
| David Jaynee | Member of Supervisory Board |
| Karen Smith | Member of Supervisory Board |
| Robert Foster | Member of Supervisory Board |
| Jeffrey Bailey | Member of Supervisory Board |
| Jill Leversage | Member of Supervisory Board |
| R. MacKay-Dunn | Member of Supervisory Board |